Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types
- PMID: 9989495
- DOI: 10.1016/s0092-8674(00)80957-5
Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types
Abstract
MALT B cell lymphomas with t(1;14)(p22;q32) showed a recurrent breakpoint upstream of the promoter of a novel gene, Bcl10. Bcl10 is a cellular homolog of the equine herpesvirus-2 E10 gene: both contain an amino-terminal caspase recruitment domain (CARD) homologous to that found in several apoptotic molecules. Bcl10 and E10 activated NF-kappaB but caused apoptosis of 293 cells. Bcl10 expressed in a MALT lymphoma exhibited a frameshift mutation resulting in truncation distal to the CARD. Truncated Bcl10 activated NF-kappaB but did not induce apoptosis. Wild-type Bcl10 suppressed transformation, whereas mutant forms had lost this activity and displayed gain-of-function transforming activity. Similar mutations were detected in other tumor types, indicating that Bcl10 may be commonly involved in the pathogenesis of human malignancy.
Comment in
-
Lack of BCL10 mutations in germ cell tumors and B cell lymphomas.Cell. 1999 Jun 11;97(6):683-4; discussion 686-8. doi: 10.1016/s0092-8674(00)80781-3. Cell. 1999. PMID: 10380920 No abstract available.
-
Absence of BCL10 mutations in human malignant mesothelioma.Cell. 1999 Jun 11;97(6):684-6; discussion 686-8. doi: 10.1016/s0092-8674(02)09765-9. Cell. 1999. PMID: 10380921 No abstract available.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
